Cambrex Corporation

Cambrex Corporation is a life sciences company providing products and services for drug discovery, development and manufacturing processes.

Cambrex was founded in 1981 as CasChem Group. With the name change in 1987, Cambrex was listed on NASDAQ. Since 1991, Cambrex entered the life science area with several acquisitions, like the one of BioWhittaker in 1997. Today, Cambrex Corporation (NYSE:CBM) is a life science company providing products and services for drug discovery, development and manufacturing processes. The company operates in the three business segments Human Health (60%), Bioproducts (29%) and Biopharma (11%). It employs approximately 1900 people worldwide. Subsidiaries of Cambrex include: Cambrex Bio Science Hopkinton, Inc., Cambrex Bio Science Baltimore, Inc., Cambrex Bio Science Walkersville, Inc., Cambrex Bio Science Rockland, Inc. and Cambrex Charles City, Inc. Rutherford Chemicals, Cambrex former specialty chemical subsidiary, was sold in fall 2003.

James A. Mack, President, CEO, Executive Chairman
Gary L. Mossman, Executive Vice President, COO
Luke M. Beshar, Executive Vice President, CFO

One Meadowlands Plaza
East Rutherford, New Jersey 07073
USA
Phone: +1-201-804-3000
Fax: +1-201-804-9852

The company is divided into different units, each focusing on different aspects regarding products and services for drug discovery, development and manufacturing processes. The human health unit produces active pharmaceutical ingredients and intermediates used for cosmetics and food additives. The bioproducts unit provides cell culture products, endotoxon detection products, electrophoresis and chromatography products. The Cambrex Pharma unit employs technologies such as nitration, hydrogenation, high energy reactions and chiral synthesis. The technology focuses large-scale enzymatic transformations, nicotine based products and high containment products for oncology. The Cambrex Biopharmaceuticals Services division provides biopharmaceutical process development, analytical and cGMP manufacturing services to the pharmaceutical and biotechnology industry.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.